{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:18:57Z","timestamp":1794345537087,"version":"4.9.0"},"reference-count":108,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Between 5% and 30% of malignant neoplasms involving the ovary are metastatic. A variety of neoplasms can metastasize to the ovary, including those from the colorectum, endometrium, breast, appendix, stomach, and cervix.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To summarize the clinical, gross, and histologic features that aid in distinguishing primary ovarian neoplasms from metastatic neoplasms. Additionally, to discuss the immunohistochemical features that help identify the primary site of origin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>Sources include literature review and cases identified from the authors\u2019 practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>There are many features that can help distinguish a primary ovarian neoplasm from a metastatic lesion. The patient\u2019s clinical symptoms and history may suggest the primary site. On radiology, the absence of ascites is suggestive of metastasis. Laboratory tests such as cancer antigen 125 (CA 125) and carcinoembryonic antigen (CEA) are helpful in distinguishing a primary versus metastatic neoplasm. Gross features that favor metastasis are bilaterality and small tumor size. Metastatic lesions often have multinodular growth and involve the surface or superficial cortex. Histologic features favoring metastasis include a nodular or infiltrative pattern, stromal desmoplasia, hilar involvement, lymphovascular invasion, and an absence of benign or borderline components. The presence of extracellular mucin and signet ring cells also suggests metastasis. Distinct histologic features can be suggestive of the primary site. Immunohistochemical stains, such as cytokeratin (CK) 7, CK20, SATB homeobox 2 (SATB2), p16, paired box 8 (PAX8), WT1 transcription factor (WT1), estrogen receptor (ER), progesterone receptor (PR), and GATA-binding protein 3 (GATA3), can also be useful in evaluating the site of origin. Distinguishing between a primary ovarian tumor and metastasis is critical for determining prognosis and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2024-0502-ra","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T20:02:24Z","timestamp":1746648144000},"page":"e81-e89","source":"Crossref","is-referenced-by-count":3,"title":["Metastatic Malignancies to the Ovaries: Often Hiding in Plain Sight"],"prefix":"10.5858","volume":"150","author":[{"given":"Olivia J.","family":"Leung","sequence":"first","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshia E.","family":"Mora","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Brunetti","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"1","key":"i1543-2165-150-4-e81-b01","series-title":"Virchows Arch","first-page":"79","article-title":"A national population-based study provides insight in the origin of malignancies metastatic to the ovary","volume":"467","author":"Bruls","year":"2015","unstructured":"Bruls J,\nSimons M,\nOverbeek LI,\nBulten J,\nMassuger LF,\nNagtegaal ID. A national population-based study provides insight in the origin of malignancies metastatic to the ovary. Virchows Arch. 2015;467(1):79\u201386. doi:10.1007\/s00428-015-1771-2"},{"issue":"1","key":"i1543-2165-150-4-e81-b02","series-title":"Obstet Gynecol","first-page":"77","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","unstructured":"Aletti GD,\nDowdy SC,\nGostout BS, et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006;107(1):77\u201385. doi:10.1097\/01.AOG.0000192407.04428.bb"},{"issue":"3","key":"i1543-2165-150-4-e81-b03","series-title":"Cancer Treat Rev","first-page":"151","article-title":"Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer","volume":"26","author":"Stockler","year":"2000","unstructured":"Stockler M,\nWilcken NR,\nGhersi D,\nSimes RJ. Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev. 2000;26(3):151\u2013168. doi:10.1053\/ctrv.1999.0161"},{"issue":"2","key":"i1543-2165-150-4-e81-b04","series-title":"Gynecol Oncol","first-page":"235","article-title":"The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries","volume":"98","author":"Ayhan","year":"2005","unstructured":"Ayhan A,\nGuvenal T,\nSalman MC,\nOzyuncu O,\nSakinci M,\nBasaran M. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol. 2005;98(2):235\u2013241. doi:10.1016\/j.ygyno.2005.05.028"},{"issue":"1","key":"i1543-2165-150-4-e81-b05","series-title":"Virchows Arch","first-page":"69","article-title":"The challenge of diagnosing a malignancy metastatic to the ovary: clinicopathological characteristics vary and morphology can be different from that of the corresponding primary tumor","volume":"470","author":"Lobo","year":"2017","unstructured":"Lobo J,\nMachado B,\nVieira R,\nBartosch C. The challenge of diagnosing a malignancy metastatic to the ovary: clinicopathological characteristics vary and morphology can be different from that of the corresponding primary tumor. Virchows Arch. 2017;470(1):69\u201380. doi:10.1007\/s00428-016-2029-3"},{"issue":"4","key":"i1543-2165-150-4-e81-b06","series-title":"Abdom Radiol","first-page":"1493","article-title":"Imaging in secondary tumors of the ovary","volume":"44","author":"Karaosmanoglu","year":"2019","unstructured":"Karaosmanoglu AD,\nOnur MR,\nSalman MC, et al. Imaging in secondary tumors of the ovary. Abdom Radiol. 2019;44(4):1493\u20131505. doi:10.1007\/s00261-018-1809-4"},{"issue":"1","key":"i1543-2165-150-4-e81-b07","series-title":"Am J Surg Pathol","first-page":"128","article-title":"Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification","volume":"32","author":"Yemelyanova","year":"2008","unstructured":"Yemelyanova AV,\nVang R,\nJudson K,\nWu LSF,\nRonnett BM. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Pathol. 2008;32(1):128\u2013138. doi:10.1097\/PAS.0b013e3180690d2d"},{"issue":"1","key":"i1543-2165-150-4-e81-b08","series-title":"Arch Pathol Lab Med","first-page":"47","article-title":"Frozen section diagnosis of ovarian epithelial tumors: diagnostic pearls and pitfalls","volume":"143","author":"Buza","year":"2019","unstructured":"Buza N. Frozen section diagnosis of ovarian epithelial tumors: diagnostic pearls and pitfalls. Arch Pathol Lab Med. 2019;143(1):47\u201364. doi:10.5858\/arpa.2018-0289-RA"},{"issue":"12","key":"i1543-2165-150-4-e81-b09","series-title":"Am Fam Physician","first-page":"813","article-title":"Screening for ovarian cancer","volume":"97","author":"Fan","year":"2018","unstructured":"Fan T,\nUptegraft C. Screening for ovarian cancer. Am Fam Physician. 2018;97(12):813\u2013814."},{"key":"i1543-2165-150-4-e81-b10","series-title":"Curr Probl Diagn Radiol","first-page":"S0363-0188(24)00184-1","article-title":"Differentiating primary from metastatic ovarian tumors of gastrointestinal origin by CT","author":"Li","year":"2024","unstructured":"Li O,\nHamadeh A,\nPourvaziri A, et al. Differentiating primary from metastatic ovarian tumors of gastrointestinal origin by CT. Curr Probl Diagn Radiol. 2024:S0363-0188(24)00184-1. doi:10.1067\/j.cpradiol.2024.10.011"},{"issue":"9","key":"i1543-2165-150-4-e81-b11","series-title":"Am J Surg Pathol","first-page":"1130","article-title":"Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases","volume":"30","author":"Vang","year":"2006","unstructured":"Vang R,\nGown AM,\nBarry TS, et al. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol. 2006;30(9):1130\u20131139. doi:10.1097\/01.pas.0000213281.43036.bb"},{"issue":"3","key":"i1543-2165-150-4-e81-b12","series-title":"Am J Surg Pathol","first-page":"281","article-title":"The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases","volume":"27","author":"Lee","year":"2003","unstructured":"Lee KR,\nYoung RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003;27(3):281\u2013292. doi:10.1097\/00000478-200303000-00001"},{"issue":"10","key":"i1543-2165-150-4-e81-b13","series-title":"Cureus","first-page":"e30561","article-title":"Aetiology, epidemiology, histopathology, classification, detailed evaluation, and treatment of ovarian cancer","volume":"14","author":"Zamwar","year":"2022","unstructured":"Zamwar UM,\nAnjankar AP. Aetiology, epidemiology, histopathology, classification, detailed evaluation, and treatment of ovarian cancer. Cureus. 2022;14(10):e30561. doi:10.7759\/cureus.30561"},{"issue":"10","key":"i1543-2165-150-4-e81-b14","series-title":"Arch Pathol Lab Med","first-page":"1289","article-title":"Signet ring stromal cell tumor: a legitimate (benign) mimic of Krukenberg tumor","volume":"142","author":"DeCoste","year":"2018","unstructured":"DeCoste R,\nOffman SL. Signet ring stromal cell tumor: a legitimate (benign) mimic of Krukenberg tumor. Arch Pathol Lab Med. 2018;142(10):1289\u20131291. doi:10.5858\/arpa.2017-0272-RS"},{"issue":"Iss 1 suppl 1","key":"i1543-2165-150-4-e81-b15","series-title":"Int J Gynecol Pathol","first-page":"S75","article-title":"Guidelines to aid in the distinction of endometrial and endocervical carcinomas, and the distinction of independent primary carcinomas of the endometrium and adnexa from metastatic spread between these and other sites","volume":"38","author":"Stewart","year":"2019","unstructured":"Stewart CJR,\nCrum CP,\nMcCluggage WG, et al. Guidelines to aid in the distinction of endometrial and endocervical carcinomas, and the distinction of independent primary carcinomas of the endometrium and adnexa from metastatic spread between these and other sites. Int J Gynecol Pathol. 2019;38 suppl 1(Iss 1 suppl 1):S75\u2013S92. doi:10.1097\/PGP.0000000000000553"},{"issue":"4","key":"i1543-2165-150-4-e81-b16","series-title":"Int J Gynecol Pathol","first-page":"391","article-title":"Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas","volume":"21","author":"Ji","year":"2002","unstructured":"Ji H,\nIsacson C,\nSeidman JD,\nKurman RJ,\nRonnett BM. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol. 2002;21(4):391\u2013400. doi:10.1097\/00004347-200210000-00009"},{"key":"i1543-2165-150-4-e81-b17","series-title":"Hum Pathol","first-page":"96","article-title":"Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases","volume":"51","author":"Liang","year":"2016","unstructured":"Liang L,\nHuang H,\nDadhania V,\nZhang J,\nZhang M,\nLiu J. Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases. Hum Pathol. 2016;51:96\u2013102. doi:10.1016\/j.humpath.2015.12.017"},{"key":"i1543-2165-150-4-e81-b18","series-title":"Hum Pathol","first-page":"309","article-title":"Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosis","volume":"85","author":"Karpathiou","year":"2019","unstructured":"Karpathiou G,\nMatias-Guiu X,\nMobarki M, et al. Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosis. Hum Pathol. 2019;85:309\u2013312. doi:10.1016\/j.humpath.2018.08.015"},{"issue":"9","key":"i1543-2165-150-4-e81-b19","series-title":"Am J Surg Pathol","first-page":"1067","article-title":"Malignant mesotheliomas presenting as ovarian masses: a report of nine cases, including two primary ovarian mesotheliomas","volume":"20","author":"Clement","year":"1996","unstructured":"Clement PB,\nYoung RH,\nScully RE. Malignant mesotheliomas presenting as ovarian masses: a report of nine cases, including two primary ovarian mesotheliomas. Am J Surg Pathol. 1996;20(9):1067\u20131080. doi:10.1097\/00000478-199609000-00004"},{"issue":"3","key":"i1543-2165-150-4-e81-b20","series-title":"Adv Anat Pathol","first-page":"149","article-title":"From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part II","volume":"14","author":"Young","year":"2007","unstructured":"Young RH. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part II. Adv Anat Pathol. 2007;14(3):149\u2013177. doi:10.1097\/PAP.0b013e3180504abf"},{"issue":"2","key":"i1543-2165-150-4-e81-b21","series-title":"Am J Surg Pathol","first-page":"177","article-title":"Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge","volume":"30","author":"Lewis","year":"2006","unstructured":"Lewis MR,\nDeavers MT,\nSilva EG,\nMalpica A. Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge. Am J Surg Pathol. 2006;30(2):177\u2013184. doi:10.1097\/01.pas.0000176436.26821.8a"},{"issue":"6","key":"i1543-2165-150-4-e81-b22","series-title":"Mod Pathol","first-page":"751","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","unstructured":"Ozcan A,\nShen SS,\nHamilton C, et al. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol. 2011;24(6):751\u2013764. doi:10.1038\/modpathol.2011.3"},{"issue":"10","key":"i1543-2165-150-4-e81-b23","series-title":"Am J Surg Pathol","first-page":"1425","article-title":"Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence","volume":"33","author":"Pai","year":"2009","unstructured":"Pai RK,\nBeck AH,\nNorton JA,\nLongacre TA. Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol. 2009;33(10):1425\u20131439. doi:10.1097\/PAS.0b013e3181af6067"},{"issue":"1","key":"i1543-2165-150-4-e81-b24","series-title":"Int J Gynecol Pathol","first-page":"1","article-title":"An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary, and comparison with primary ovarian mucinous tumors","volume":"33","author":"Stewart","year":"2014","unstructured":"Stewart CJR,\nArdakani NM,\nDoherty DA,\nYoung RH. An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary, and comparison with primary ovarian mucinous tumors: Int J Gynecol Pathol. 2014;33(1):1\u201310. doi:10.1097\/PGP.0b013e318284e070"},{"issue":"1","key":"i1543-2165-150-4-e81-b25","series-title":"Diagn Pathol","first-page":"20","article-title":"Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics","volume":"16","author":"Dundr","year":"2021","unstructured":"Dundr P,\nSingh N,\nNo\u017ei\u010dkov\u00e1 B,\nN\u011bmejcov\u00e1 K,\nB\u00e1rt\u016f M,\nStru\u017einsk\u00e1 I. Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics. Diagn Pathol. 2021;16(1):20. doi:10.1186\/s13000-021-01079-2"},{"issue":"6","key":"i1543-2165-150-4-e81-b26","series-title":"Int J Gynecol Pathol","first-page":"507","article-title":"Ovarian metastases of breast cancers with signet ring cells: a report of 17 cases including 14 Krukenberg tumors","volume":"37","author":"Bennett","year":"2018","unstructured":"Bennett JA,\nYoung RH,\nChuang AY,\nLerwill MF. Ovarian metastases of breast cancers with signet ring cells: a report of 17 cases including 14 Krukenberg tumors. Int J Gynecol Pathol. 2018;37(6):507\u2013515. doi:10.1097\/PGP.0000000000000462"},{"issue":"3","key":"i1543-2165-150-4-e81-b27","series-title":"Am J Surg Pathol","first-page":"277","article-title":"Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations","volume":"30","author":"Kiyokawa","year":"2006","unstructured":"Kiyokawa T,\nYoung RH,\nScully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol. 2006;30(3):277\u2013299. doi:10.1097\/01.pas.0000190787.85024.cb"},{"issue":"2","key":"i1543-2165-150-4-e81-b28","series-title":"Am J Surg Pathol","first-page":"276","article-title":"Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors","volume":"35","author":"Meriden","year":"2011","unstructured":"Meriden Z,\nYemelyanova AV,\nVang R,\nRonnett BM. Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors. Am J Surg Pathol. 2011;35(2):276\u2013288. doi:10.1097\/PAS.0b013e31820508d0"},{"issue":"1","key":"i1543-2165-150-4-e81-b29","series-title":"Mod Pathol","first-page":"128","article-title":"Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles","volume":"27","author":"McConechy","year":"2014","unstructured":"McConechy MK,\nDing J,\nSenz J, et al. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod Pathol. 2014;27(1):128\u2013134. doi:10.1038\/modpathol.2013.107"},{"issue":"3","key":"i1543-2165-150-4-e81-b30","series-title":"Int J Cancer","first-page":"556","article-title":"Molecular genetic evidence that endometriosis is a precursor of ovarian cancer","volume":"119","author":"Prowse","year":"2006","unstructured":"Prowse AH,\nManek S,\nVarma R, et al. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. Int J Cancer. 2006;119(3):556\u2013562. doi:10.1002\/ijc.21845"},{"issue":"5","key":"i1543-2165-150-4-e81-b31","series-title":"Int J Gynecol Pathol","first-page":"412","article-title":"Uterine carcinosarcomas: clinical, histopathologic and immunohistochemical characteristics","volume":"36","author":"Chen","year":"2017","unstructured":"Chen X,\nArend R,\nHamele-Bena D, et al. Uterine carcinosarcomas: clinical, histopathologic and immunohistochemical characteristics. Int J Gynecol Pathol. 2017;36(5):412\u2013419. doi:10.1097\/PGP.0000000000000346"},{"issue":"4","key":"i1543-2165-150-4-e81-b32","series-title":"Anticancer Res","first-page":"1327","article-title":"Clear cell carcinoma of the endometrium: a biological and clinical enigma","volume":"30","author":"Gadducci","year":"2010","unstructured":"Gadducci A,\nCosio S,\nSpirito N,\nCionini L. Clear cell carcinoma of the endometrium: a biological and clinical enigma. Anticancer Res. 2010;30(4):1327\u20131334."},{"issue":"2","key":"i1543-2165-150-4-e81-b33","series-title":"Int J Gynecol Pathol","first-page":"158","article-title":"Immunohistochemical detection of the Wilms\u2019 tumor gene (WT1) in epithelial ovarian tumors","volume":"19","author":"Shimizu","year":"2000","unstructured":"Shimizu M,\nToki T,\nTakagi Y,\nKonishi I,\nFujii S. Immunohistochemical detection of the Wilms\u2019 tumor gene (WT1) in epithelial ovarian tumors: Int J Gynecol Pathol. 2000;19(2):158\u2013163. doi:10.1097\/00004347-200004000-00010"},{"issue":"5","key":"i1543-2165-150-4-e81-b34","series-title":"Am J Surg Pathol","first-page":"667","article-title":"Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance","volume":"39","author":"Roma","year":"2015","unstructured":"Roma AA,\nDiaz De Vivar A,\nPark KJ, et al. Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance. Am J Surg Pathol. 2015;39(5):667\u2013672. doi:10.1097\/PAS.0000000000000402"},{"issue":"12","key":"i1543-2165-150-4-e81-b35","series-title":"Am J Surg Pathol","first-page":"1835","article-title":"Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms","volume":"32","author":"Ronnett","year":"2008","unstructured":"Ronnett BM,\nYemelyanova AV,\nVang R, et al. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol. 2008;32(12):1835\u20131853. doi:10.1097\/PAS.0b013e3181758831"},{"issue":"11","key":"i1543-2165-150-4-e81-b36","series-title":"Am J Surg Pathol","first-page":"1449","article-title":"Gastric-type endocervical adenocarcinoma: an aggressive tumor with unusual metastatic patterns and poor prognosis","volume":"39","author":"Karamurzin","year":"2015","unstructured":"Karamurzin YS,\nKiyokawa T,\nParkash V, et al. Gastric-type endocervical adenocarcinoma: an aggressive tumor with unusual metastatic patterns and poor prognosis. Am J Surg Pathol. 2015;39(11):1449\u20131457. doi:10.1097\/PAS.0000000000000532"},{"issue":"10","key":"i1543-2165-150-4-e81-b37","series-title":"Int J Clin Exp Pathol","first-page":"2168","article-title":"Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization","volume":"6","author":"Sheng","year":"2013","unstructured":"Sheng Z,\nMinato H,\nSasagawa T, et al. Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization. Int J Clin Exp Pathol. 2013;6(10):2168\u20132177."},{"issue":"6","key":"i1543-2165-150-4-e81-b38","series-title":"Anticancer Res","first-page":"3669","article-title":"Malignant transformation in mature cystic teratomas of the ovary: case reports and review of the literature","volume":"38","author":"Gadducci","year":"2018","unstructured":"Gadducci A,\nPistolesi S,\nGuerrieri ME,\nCosio S,\nCarbone FG,\nNaccarato AG. Malignant transformation in mature cystic teratomas of the ovary: case reports and review of the literature. Anticancer Res. 2018;38(6):3669\u20133675. doi:10.21873\/anticanres.12644"},{"issue":"11","key":"i1543-2165-150-4-e81-b39","series-title":"J Clin Diagn Res","first-page":"FD14-6","article-title":"Collision tumours of ovary: a very rare case series","volume":"8","author":"Singh","year":"2014","unstructured":"Singh AR,\nSingh M. Collision tumours of ovary: a very rare case series. J Clin Diagn Res. 2014;8(11):FD14-6. doi:10.7860\/JCDR\/2014\/11138.5222"},{"issue":"3","key":"i1543-2165-150-4-e81-b40","series-title":"Adv Anat Pathol","first-page":"114","article-title":"An algorithmic immunohistochemical approach to define tumor type and assign site of origin","volume":"27","author":"Bellizzi","year":"2020","unstructured":"Bellizzi AM. An algorithmic immunohistochemical approach to define tumor type and assign site of origin. Adv Anat Pathol. 2020;27(3):114\u2013163. doi:10.1097\/PAP.0000000000000256"},{"issue":"12","key":"i1543-2165-150-4-e81-b41","series-title":"Am J Surg Pathol","first-page":"1830","article-title":"Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases","volume":"35","author":"Chu","year":"2011","unstructured":"Chu PG,\nChung L,\nWeiss LM,\nLau SK. Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases. Am J Surg Pathol. 2011;35(12):1830\u20131836. doi:10.1097\/PAS.0b013e3182299c25"},{"issue":"3","key":"i1543-2165-150-4-e81-b42","series-title":"Am J Surg Pathol","first-page":"419","article-title":"SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type","volume":"40","author":"Moh","year":"2016","unstructured":"Moh M,\nKrings G,\nAtes D,\nAysal A,\nKim GE,\nRabban JT. SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type. Am J Surg Pathol. 2016;40(3):419\u2013432. doi:10.1097\/PAS.0000000000000553"},{"issue":"5","key":"i1543-2165-150-4-e81-b43","series-title":"Am J Surg Pathol","first-page":"653","article-title":"p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas","volume":"31","author":"Vang","year":"2007","unstructured":"Vang R,\nGown AM,\nFarinola M, et al. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Am J Surg Pathol. 2007;31(5):653\u2013663. doi:10.1097\/01.pas.0000213369.71676.25"},{"issue":"3","key":"i1543-2165-150-4-e81-b44","series-title":"Histopathology","first-page":"342","article-title":"p16 immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection","volume":"57","author":"Houghton","year":"2010","unstructured":"Houghton O,\nJamison J,\nWilson R,\nCarson J,\nMcCluggage WG. p16 immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection. Histopathology. 2010;57(3):342\u2013350. doi:10.1111\/j.1365-2559.2010.03632.x"},{"issue":"10","key":"i1543-2165-150-4-e81-b45","series-title":"Am J Surg Pathol","first-page":"1566","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","unstructured":"Nonaka D,\nChiriboga L,\nSoslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol. 2008;32(10):1566\u20131571. doi:10.1097\/PAS.0b013e31816d71ad"},{"issue":"5","key":"i1543-2165-150-4-e81-b46","series-title":"Int J Gynecol Pathol","first-page":"430","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"K\u00f6bel","year":"2016","unstructured":"K\u00f6bel M,\nRahimi K,\nRambau PF, et al. An immunohistochemical algorithm for ovarian carcinoma typing. Int J Gynecol Pathol. 2016;35(5):430\u2013441. doi:10.1097\/PGP.0000000000000274"},{"issue":"1","key":"i1543-2165-150-4-e81-b47","series-title":"Mod Pathol","first-page":"97","article-title":"Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases","volume":"19","author":"Vang","year":"2006","unstructured":"Vang R,\nGown AM,\nBarry TS,\nWheeler DT,\nRonnett BM. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Mod Pathol. 2006;19(1):97\u2013105. doi:10.1038\/modpathol.3800510"},{"issue":"1","key":"i1543-2165-150-4-e81-b48","series-title":"Am J Clin Pathol","first-page":"57","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues","volume":"138","author":"Liu","year":"2012","unstructured":"Liu H,\nShi J,\nWilkerson ML,\nLin F. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues. Am J Clin Pathol. 2012;138(1):57\u201364. doi:10.1309\/AJCP5UAFMSA9ZQBZ"},{"issue":"12","key":"i1543-2165-150-4-e81-b49","series-title":"Am J Surg Pathol","first-page":"1596","article-title":"A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract","volume":"42","author":"Pors","year":"2018","unstructured":"Pors J,\nCheng A,\nLeo JM,\nKinloch MA,\nGilks B,\nHoang L. A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract. Am J Surg Pathol. 2018;42(12):1596\u20131606. doi:10.1097\/PAS.0000000000001142"},{"issue":"5","key":"i1543-2165-150-4-e81-b50","series-title":"Clin Exp Metastasis","first-page":"295","article-title":"The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review","volume":"34","author":"Kube\u010dek","year":"2017","unstructured":"Kube\u010dek O,\nLaco J,\n\u0160pa\u010dek J, et al. The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. Clin Exp Metastasis. 2017;34(5):295\u2013307. doi:10.1007\/s10585-017-9856-8"},{"issue":"2","key":"i1543-2165-150-4-e81-b51","series-title":"Cell","first-page":"291","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","unstructured":"Hoadley KA,\nYau C,\nHinoue T, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell. 2018;173(2):291\u2013304.e6. doi:10.1016\/j.cell.2018.03.022"},{"issue":"2","key":"i1543-2165-150-4-e81-b52","series-title":"Int J Cancer","first-page":"478","article-title":"Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome","volume":"147","author":"Reijnen","year":"2020","unstructured":"Reijnen C,\nK\u00fcsters-Vandevelde HVN,\nLigtenberg MJL, et al. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome. Int J Cancer. 2020;147(2):478\u2013489. doi:10.1002\/ijc.32907"},{"issue":"1","key":"i1543-2165-150-4-e81-b53","series-title":"Gynecol Oncol","first-page":"333","article-title":"The current landscape of molecular profiling in the treatment of epithelial ovarian cancer","volume":"160","author":"Haunschild","year":"2021","unstructured":"Haunschild CE,\nTewari KS. The current landscape of molecular profiling in the treatment of epithelial ovarian cancer. Gynecol Oncol. 2021;160(1):333\u2013345. doi:10.1016\/j.ygyno.2020.09.043"},{"issue":"1","key":"i1543-2165-150-4-e81-b54","series-title":"JAMA Netw Open","first-page":"e2453588","article-title":"KRAS mutation status and treatment outcomes in patients with metastatic pancreatic adenocarcinoma","volume":"8","author":"Norton","year":"2025","unstructured":"Norton C,\nShaw MS,\nRubnitz Z, et al. KRAS mutation status and treatment outcomes in patients with metastatic pancreatic adenocarcinoma. JAMA Netw Open. 2025;8(1):e2453588. doi:10.1001\/jamanetworkopen.2024.53588"},{"issue":"1","key":"i1543-2165-150-4-e81-b01","series-title":"Virchows Arch","first-page":"79","article-title":"A national population-based study provides insight in the origin of malignancies metastatic to the ovary","volume":"467","author":"Bruls","year":"2015","unstructured":"Bruls J,\nSimons M,\nOverbeek LI,\nBulten J,\nMassuger LF,\nNagtegaal ID. A national population-based study provides insight in the origin of malignancies metastatic to the ovary. Virchows Arch. 2015;467(1):79\u201386. doi:10.1007\/s00428-015-1771-2"},{"issue":"1","key":"i1543-2165-150-4-e81-b02","series-title":"Obstet Gynecol","first-page":"77","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","unstructured":"Aletti GD,\nDowdy SC,\nGostout BS, et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006;107(1):77\u201385. doi:10.1097\/01.AOG.0000192407.04428.bb"},{"issue":"3","key":"i1543-2165-150-4-e81-b03","series-title":"Cancer Treat Rev","first-page":"151","article-title":"Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer","volume":"26","author":"Stockler","year":"2000","unstructured":"Stockler M,\nWilcken NR,\nGhersi D,\nSimes RJ. Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev. 2000;26(3):151\u2013168. doi:10.1053\/ctrv.1999.0161"},{"issue":"2","key":"i1543-2165-150-4-e81-b04","series-title":"Gynecol Oncol","first-page":"235","article-title":"The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries","volume":"98","author":"Ayhan","year":"2005","unstructured":"Ayhan A,\nGuvenal T,\nSalman MC,\nOzyuncu O,\nSakinci M,\nBasaran M. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol. 2005;98(2):235\u2013241. doi:10.1016\/j.ygyno.2005.05.028"},{"issue":"1","key":"i1543-2165-150-4-e81-b05","series-title":"Virchows Arch","first-page":"69","article-title":"The challenge of diagnosing a malignancy metastatic to the ovary: clinicopathological characteristics vary and morphology can be different from that of the corresponding primary tumor","volume":"470","author":"Lobo","year":"2017","unstructured":"Lobo J,\nMachado B,\nVieira R,\nBartosch C. The challenge of diagnosing a malignancy metastatic to the ovary: clinicopathological characteristics vary and morphology can be different from that of the corresponding primary tumor. Virchows Arch. 2017;470(1):69\u201380. doi:10.1007\/s00428-016-2029-3"},{"issue":"4","key":"i1543-2165-150-4-e81-b06","series-title":"Abdom Radiol","first-page":"1493","article-title":"Imaging in secondary tumors of the ovary","volume":"44","author":"Karaosmanoglu","year":"2019","unstructured":"Karaosmanoglu AD,\nOnur MR,\nSalman MC, et al. Imaging in secondary tumors of the ovary. Abdom Radiol. 2019;44(4):1493\u20131505. doi:10.1007\/s00261-018-1809-4"},{"issue":"1","key":"i1543-2165-150-4-e81-b07","series-title":"Am J Surg Pathol","first-page":"128","article-title":"Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification","volume":"32","author":"Yemelyanova","year":"2008","unstructured":"Yemelyanova AV,\nVang R,\nJudson K,\nWu LSF,\nRonnett BM. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Pathol. 2008;32(1):128\u2013138. doi:10.1097\/PAS.0b013e3180690d2d"},{"issue":"1","key":"i1543-2165-150-4-e81-b08","series-title":"Arch Pathol Lab Med","first-page":"47","article-title":"Frozen section diagnosis of ovarian epithelial tumors: diagnostic pearls and pitfalls","volume":"143","author":"Buza","year":"2019","unstructured":"Buza N. Frozen section diagnosis of ovarian epithelial tumors: diagnostic pearls and pitfalls. Arch Pathol Lab Med. 2019;143(1):47\u201364. doi:10.5858\/arpa.2018-0289-RA"},{"issue":"12","key":"i1543-2165-150-4-e81-b09","series-title":"Am Fam Physician","first-page":"813","article-title":"Screening for ovarian cancer","volume":"97","author":"Fan","year":"2018","unstructured":"Fan T,\nUptegraft C. Screening for ovarian cancer. Am Fam Physician. 2018;97(12):813\u2013814."},{"key":"i1543-2165-150-4-e81-b10","series-title":"Curr Probl Diagn Radiol","first-page":"S0363-0188(24)00184-1","article-title":"Differentiating primary from metastatic ovarian tumors of gastrointestinal origin by CT","author":"Li","year":"2024","unstructured":"Li O,\nHamadeh A,\nPourvaziri A, et al. Differentiating primary from metastatic ovarian tumors of gastrointestinal origin by CT. Curr Probl Diagn Radiol. 2024:S0363-0188(24)00184-1. doi:10.1067\/j.cpradiol.2024.10.011"},{"issue":"9","key":"i1543-2165-150-4-e81-b11","series-title":"Am J Surg Pathol","first-page":"1130","article-title":"Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases","volume":"30","author":"Vang","year":"2006","unstructured":"Vang R,\nGown AM,\nBarry TS, et al. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol. 2006;30(9):1130\u20131139. doi:10.1097\/01.pas.0000213281.43036.bb"},{"issue":"3","key":"i1543-2165-150-4-e81-b12","series-title":"Am J Surg Pathol","first-page":"281","article-title":"The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases","volume":"27","author":"Lee","year":"2003","unstructured":"Lee KR,\nYoung RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003;27(3):281\u2013292. doi:10.1097\/00000478-200303000-00001"},{"issue":"10","key":"i1543-2165-150-4-e81-b13","series-title":"Cureus","first-page":"e30561","article-title":"Aetiology, epidemiology, histopathology, classification, detailed evaluation, and treatment of ovarian cancer","volume":"14","author":"Zamwar","year":"2022","unstructured":"Zamwar UM,\nAnjankar AP. Aetiology, epidemiology, histopathology, classification, detailed evaluation, and treatment of ovarian cancer. Cureus. 2022;14(10):e30561. doi:10.7759\/cureus.30561"},{"issue":"10","key":"i1543-2165-150-4-e81-b14","series-title":"Arch Pathol Lab Med","first-page":"1289","article-title":"Signet ring stromal cell tumor: a legitimate (benign) mimic of Krukenberg tumor","volume":"142","author":"DeCoste","year":"2018","unstructured":"DeCoste R,\nOffman SL. Signet ring stromal cell tumor: a legitimate (benign) mimic of Krukenberg tumor. Arch Pathol Lab Med. 2018;142(10):1289\u20131291. doi:10.5858\/arpa.2017-0272-RS"},{"issue":"Iss 1 suppl 1","key":"i1543-2165-150-4-e81-b15","series-title":"Int J Gynecol Pathol","first-page":"S75","article-title":"Guidelines to aid in the distinction of endometrial and endocervical carcinomas, and the distinction of independent primary carcinomas of the endometrium and adnexa from metastatic spread between these and other sites","volume":"38","author":"Stewart","year":"2019","unstructured":"Stewart CJR,\nCrum CP,\nMcCluggage WG, et al. Guidelines to aid in the distinction of endometrial and endocervical carcinomas, and the distinction of independent primary carcinomas of the endometrium and adnexa from metastatic spread between these and other sites. Int J Gynecol Pathol. 2019;38 suppl 1(Iss 1 suppl 1):S75\u2013S92. doi:10.1097\/PGP.0000000000000553"},{"issue":"4","key":"i1543-2165-150-4-e81-b16","series-title":"Int J Gynecol Pathol","first-page":"391","article-title":"Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas","volume":"21","author":"Ji","year":"2002","unstructured":"Ji H,\nIsacson C,\nSeidman JD,\nKurman RJ,\nRonnett BM. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol. 2002;21(4):391\u2013400. doi:10.1097\/00004347-200210000-00009"},{"key":"i1543-2165-150-4-e81-b17","series-title":"Hum Pathol","first-page":"96","article-title":"Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases","volume":"51","author":"Liang","year":"2016","unstructured":"Liang L,\nHuang H,\nDadhania V,\nZhang J,\nZhang M,\nLiu J. Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases. Hum Pathol. 2016;51:96\u2013102. doi:10.1016\/j.humpath.2015.12.017"},{"key":"i1543-2165-150-4-e81-b18","series-title":"Hum Pathol","first-page":"309","article-title":"Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosis","volume":"85","author":"Karpathiou","year":"2019","unstructured":"Karpathiou G,\nMatias-Guiu X,\nMobarki M, et al. Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosis. Hum Pathol. 2019;85:309\u2013312. doi:10.1016\/j.humpath.2018.08.015"},{"issue":"9","key":"i1543-2165-150-4-e81-b19","series-title":"Am J Surg Pathol","first-page":"1067","article-title":"Malignant mesotheliomas presenting as ovarian masses: a report of nine cases, including two primary ovarian mesotheliomas","volume":"20","author":"Clement","year":"1996","unstructured":"Clement PB,\nYoung RH,\nScully RE. Malignant mesotheliomas presenting as ovarian masses: a report of nine cases, including two primary ovarian mesotheliomas. Am J Surg Pathol. 1996;20(9):1067\u20131080. doi:10.1097\/00000478-199609000-00004"},{"issue":"3","key":"i1543-2165-150-4-e81-b20","series-title":"Adv Anat Pathol","first-page":"149","article-title":"From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part II","volume":"14","author":"Young","year":"2007","unstructured":"Young RH. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part II. Adv Anat Pathol. 2007;14(3):149\u2013177. doi:10.1097\/PAP.0b013e3180504abf"},{"issue":"2","key":"i1543-2165-150-4-e81-b21","series-title":"Am J Surg Pathol","first-page":"177","article-title":"Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge","volume":"30","author":"Lewis","year":"2006","unstructured":"Lewis MR,\nDeavers MT,\nSilva EG,\nMalpica A. Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge. Am J Surg Pathol. 2006;30(2):177\u2013184. doi:10.1097\/01.pas.0000176436.26821.8a"},{"issue":"6","key":"i1543-2165-150-4-e81-b22","series-title":"Mod Pathol","first-page":"751","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","unstructured":"Ozcan A,\nShen SS,\nHamilton C, et al. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol. 2011;24(6):751\u2013764. doi:10.1038\/modpathol.2011.3"},{"issue":"10","key":"i1543-2165-150-4-e81-b23","series-title":"Am J Surg Pathol","first-page":"1425","article-title":"Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence","volume":"33","author":"Pai","year":"2009","unstructured":"Pai RK,\nBeck AH,\nNorton JA,\nLongacre TA. Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol. 2009;33(10):1425\u20131439. doi:10.1097\/PAS.0b013e3181af6067"},{"issue":"1","key":"i1543-2165-150-4-e81-b24","series-title":"Int J Gynecol Pathol","first-page":"1","article-title":"An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary, and comparison with primary ovarian mucinous tumors","volume":"33","author":"Stewart","year":"2014","unstructured":"Stewart CJR,\nArdakani NM,\nDoherty DA,\nYoung RH. An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary, and comparison with primary ovarian mucinous tumors: Int J Gynecol Pathol. 2014;33(1):1\u201310. doi:10.1097\/PGP.0b013e318284e070"},{"issue":"1","key":"i1543-2165-150-4-e81-b25","series-title":"Diagn Pathol","first-page":"20","article-title":"Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics","volume":"16","author":"Dundr","year":"2021","unstructured":"Dundr P,\nSingh N,\nNo\u017ei\u010dkov\u00e1 B,\nN\u011bmejcov\u00e1 K,\nB\u00e1rt\u016f M,\nStru\u017einsk\u00e1 I. Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics. Diagn Pathol. 2021;16(1):20. doi:10.1186\/s13000-021-01079-2"},{"issue":"6","key":"i1543-2165-150-4-e81-b26","series-title":"Int J Gynecol Pathol","first-page":"507","article-title":"Ovarian metastases of breast cancers with signet ring cells: a report of 17 cases including 14 Krukenberg tumors","volume":"37","author":"Bennett","year":"2018","unstructured":"Bennett JA,\nYoung RH,\nChuang AY,\nLerwill MF. Ovarian metastases of breast cancers with signet ring cells: a report of 17 cases including 14 Krukenberg tumors. Int J Gynecol Pathol. 2018;37(6):507\u2013515. doi:10.1097\/PGP.0000000000000462"},{"issue":"3","key":"i1543-2165-150-4-e81-b27","series-title":"Am J Surg Pathol","first-page":"277","article-title":"Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations","volume":"30","author":"Kiyokawa","year":"2006","unstructured":"Kiyokawa T,\nYoung RH,\nScully RE. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol. 2006;30(3):277\u2013299. doi:10.1097\/01.pas.0000190787.85024.cb"},{"issue":"2","key":"i1543-2165-150-4-e81-b28","series-title":"Am J Surg Pathol","first-page":"276","article-title":"Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors","volume":"35","author":"Meriden","year":"2011","unstructured":"Meriden Z,\nYemelyanova AV,\nVang R,\nRonnett BM. Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors. Am J Surg Pathol. 2011;35(2):276\u2013288. doi:10.1097\/PAS.0b013e31820508d0"},{"issue":"1","key":"i1543-2165-150-4-e81-b29","series-title":"Mod Pathol","first-page":"128","article-title":"Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles","volume":"27","author":"McConechy","year":"2014","unstructured":"McConechy MK,\nDing J,\nSenz J, et al. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod Pathol. 2014;27(1):128\u2013134. doi:10.1038\/modpathol.2013.107"},{"issue":"3","key":"i1543-2165-150-4-e81-b30","series-title":"Int J Cancer","first-page":"556","article-title":"Molecular genetic evidence that endometriosis is a precursor of ovarian cancer","volume":"119","author":"Prowse","year":"2006","unstructured":"Prowse AH,\nManek S,\nVarma R, et al. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. Int J Cancer. 2006;119(3):556\u2013562. doi:10.1002\/ijc.21845"},{"issue":"5","key":"i1543-2165-150-4-e81-b31","series-title":"Int J Gynecol Pathol","first-page":"412","article-title":"Uterine carcinosarcomas: clinical, histopathologic and immunohistochemical characteristics","volume":"36","author":"Chen","year":"2017","unstructured":"Chen X,\nArend R,\nHamele-Bena D, et al. Uterine carcinosarcomas: clinical, histopathologic and immunohistochemical characteristics. Int J Gynecol Pathol. 2017;36(5):412\u2013419. doi:10.1097\/PGP.0000000000000346"},{"issue":"4","key":"i1543-2165-150-4-e81-b32","series-title":"Anticancer Res","first-page":"1327","article-title":"Clear cell carcinoma of the endometrium: a biological and clinical enigma","volume":"30","author":"Gadducci","year":"2010","unstructured":"Gadducci A,\nCosio S,\nSpirito N,\nCionini L. Clear cell carcinoma of the endometrium: a biological and clinical enigma. Anticancer Res. 2010;30(4):1327\u20131334."},{"issue":"2","key":"i1543-2165-150-4-e81-b33","series-title":"Int J Gynecol Pathol","first-page":"158","article-title":"Immunohistochemical detection of the Wilms\u2019 tumor gene (WT1) in epithelial ovarian tumors","volume":"19","author":"Shimizu","year":"2000","unstructured":"Shimizu M,\nToki T,\nTakagi Y,\nKonishi I,\nFujii S. Immunohistochemical detection of the Wilms\u2019 tumor gene (WT1) in epithelial ovarian tumors: Int J Gynecol Pathol. 2000;19(2):158\u2013163. doi:10.1097\/00004347-200004000-00010"},{"issue":"5","key":"i1543-2165-150-4-e81-b34","series-title":"Am J Surg Pathol","first-page":"667","article-title":"Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance","volume":"39","author":"Roma","year":"2015","unstructured":"Roma AA,\nDiaz De Vivar A,\nPark KJ, et al. Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance. Am J Surg Pathol. 2015;39(5):667\u2013672. doi:10.1097\/PAS.0000000000000402"},{"issue":"12","key":"i1543-2165-150-4-e81-b35","series-title":"Am J Surg Pathol","first-page":"1835","article-title":"Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms","volume":"32","author":"Ronnett","year":"2008","unstructured":"Ronnett BM,\nYemelyanova AV,\nVang R, et al. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol. 2008;32(12):1835\u20131853. doi:10.1097\/PAS.0b013e3181758831"},{"issue":"11","key":"i1543-2165-150-4-e81-b36","series-title":"Am J Surg Pathol","first-page":"1449","article-title":"Gastric-type endocervical adenocarcinoma: an aggressive tumor with unusual metastatic patterns and poor prognosis","volume":"39","author":"Karamurzin","year":"2015","unstructured":"Karamurzin YS,\nKiyokawa T,\nParkash V, et al. Gastric-type endocervical adenocarcinoma: an aggressive tumor with unusual metastatic patterns and poor prognosis. Am J Surg Pathol. 2015;39(11):1449\u20131457. doi:10.1097\/PAS.0000000000000532"},{"issue":"10","key":"i1543-2165-150-4-e81-b37","series-title":"Int J Clin Exp Pathol","first-page":"2168","article-title":"Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization","volume":"6","author":"Sheng","year":"2013","unstructured":"Sheng Z,\nMinato H,\nSasagawa T, et al. Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization. Int J Clin Exp Pathol. 2013;6(10):2168\u20132177."},{"issue":"6","key":"i1543-2165-150-4-e81-b38","series-title":"Anticancer Res","first-page":"3669","article-title":"Malignant transformation in mature cystic teratomas of the ovary: case reports and review of the literature","volume":"38","author":"Gadducci","year":"2018","unstructured":"Gadducci A,\nPistolesi S,\nGuerrieri ME,\nCosio S,\nCarbone FG,\nNaccarato AG. Malignant transformation in mature cystic teratomas of the ovary: case reports and review of the literature. Anticancer Res. 2018;38(6):3669\u20133675. doi:10.21873\/anticanres.12644"},{"issue":"11","key":"i1543-2165-150-4-e81-b39","series-title":"J Clin Diagn Res","first-page":"FD14-6","article-title":"Collision tumours of ovary: a very rare case series","volume":"8","author":"Singh","year":"2014","unstructured":"Singh AR,\nSingh M. Collision tumours of ovary: a very rare case series. J Clin Diagn Res. 2014;8(11):FD14-6. doi:10.7860\/JCDR\/2014\/11138.5222"},{"issue":"3","key":"i1543-2165-150-4-e81-b40","series-title":"Adv Anat Pathol","first-page":"114","article-title":"An algorithmic immunohistochemical approach to define tumor type and assign site of origin","volume":"27","author":"Bellizzi","year":"2020","unstructured":"Bellizzi AM. An algorithmic immunohistochemical approach to define tumor type and assign site of origin. Adv Anat Pathol. 2020;27(3):114\u2013163. doi:10.1097\/PAP.0000000000000256"},{"issue":"12","key":"i1543-2165-150-4-e81-b41","series-title":"Am J Surg Pathol","first-page":"1830","article-title":"Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases","volume":"35","author":"Chu","year":"2011","unstructured":"Chu PG,\nChung L,\nWeiss LM,\nLau SK. Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases. Am J Surg Pathol. 2011;35(12):1830\u20131836. doi:10.1097\/PAS.0b013e3182299c25"},{"issue":"3","key":"i1543-2165-150-4-e81-b42","series-title":"Am J Surg Pathol","first-page":"419","article-title":"SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type","volume":"40","author":"Moh","year":"2016","unstructured":"Moh M,\nKrings G,\nAtes D,\nAysal A,\nKim GE,\nRabban JT. SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type. Am J Surg Pathol. 2016;40(3):419\u2013432. doi:10.1097\/PAS.0000000000000553"},{"issue":"5","key":"i1543-2165-150-4-e81-b43","series-title":"Am J Surg Pathol","first-page":"653","article-title":"p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas","volume":"31","author":"Vang","year":"2007","unstructured":"Vang R,\nGown AM,\nFarinola M, et al. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Am J Surg Pathol. 2007;31(5):653\u2013663. doi:10.1097\/01.pas.0000213369.71676.25"},{"issue":"3","key":"i1543-2165-150-4-e81-b44","series-title":"Histopathology","first-page":"342","article-title":"p16 immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection","volume":"57","author":"Houghton","year":"2010","unstructured":"Houghton O,\nJamison J,\nWilson R,\nCarson J,\nMcCluggage WG. p16 immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection. Histopathology. 2010;57(3):342\u2013350. doi:10.1111\/j.1365-2559.2010.03632.x"},{"issue":"10","key":"i1543-2165-150-4-e81-b45","series-title":"Am J Surg Pathol","first-page":"1566","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","unstructured":"Nonaka D,\nChiriboga L,\nSoslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol. 2008;32(10):1566\u20131571. doi:10.1097\/PAS.0b013e31816d71ad"},{"issue":"5","key":"i1543-2165-150-4-e81-b46","series-title":"Int J Gynecol Pathol","first-page":"430","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"K\u00f6bel","year":"2016","unstructured":"K\u00f6bel M,\nRahimi K,\nRambau PF, et al. An immunohistochemical algorithm for ovarian carcinoma typing. Int J Gynecol Pathol. 2016;35(5):430\u2013441. doi:10.1097\/PGP.0000000000000274"},{"issue":"1","key":"i1543-2165-150-4-e81-b47","series-title":"Mod Pathol","first-page":"97","article-title":"Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases","volume":"19","author":"Vang","year":"2006","unstructured":"Vang R,\nGown AM,\nBarry TS,\nWheeler DT,\nRonnett BM. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Mod Pathol. 2006;19(1):97\u2013105. doi:10.1038\/modpathol.3800510"},{"issue":"1","key":"i1543-2165-150-4-e81-b48","series-title":"Am J Clin Pathol","first-page":"57","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues","volume":"138","author":"Liu","year":"2012","unstructured":"Liu H,\nShi J,\nWilkerson ML,\nLin F. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues. Am J Clin Pathol. 2012;138(1):57\u201364. doi:10.1309\/AJCP5UAFMSA9ZQBZ"},{"issue":"12","key":"i1543-2165-150-4-e81-b49","series-title":"Am J Surg Pathol","first-page":"1596","article-title":"A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract","volume":"42","author":"Pors","year":"2018","unstructured":"Pors J,\nCheng A,\nLeo JM,\nKinloch MA,\nGilks B,\nHoang L. A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract. Am J Surg Pathol. 2018;42(12):1596\u20131606. doi:10.1097\/PAS.0000000000001142"},{"issue":"5","key":"i1543-2165-150-4-e81-b50","series-title":"Clin Exp Metastasis","first-page":"295","article-title":"The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review","volume":"34","author":"Kube\u010dek","year":"2017","unstructured":"Kube\u010dek O,\nLaco J,\n\u0160pa\u010dek J, et al. The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. Clin Exp Metastasis. 2017;34(5):295\u2013307. doi:10.1007\/s10585-017-9856-8"},{"issue":"2","key":"i1543-2165-150-4-e81-b51","series-title":"Cell","first-page":"291","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","unstructured":"Hoadley KA,\nYau C,\nHinoue T, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell. 2018;173(2):291\u2013304.e6. doi:10.1016\/j.cell.2018.03.022"},{"issue":"2","key":"i1543-2165-150-4-e81-b52","series-title":"Int J Cancer","first-page":"478","article-title":"Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome","volume":"147","author":"Reijnen","year":"2020","unstructured":"Reijnen C,\nK\u00fcsters-Vandevelde HVN,\nLigtenberg MJL, et al. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome. Int J Cancer. 2020;147(2):478\u2013489. doi:10.1002\/ijc.32907"},{"issue":"1","key":"i1543-2165-150-4-e81-b53","series-title":"Gynecol Oncol","first-page":"333","article-title":"The current landscape of molecular profiling in the treatment of epithelial ovarian cancer","volume":"160","author":"Haunschild","year":"2021","unstructured":"Haunschild CE,\nTewari KS. The current landscape of molecular profiling in the treatment of epithelial ovarian cancer. Gynecol Oncol. 2021;160(1):333\u2013345. doi:10.1016\/j.ygyno.2020.09.043"},{"issue":"1","key":"i1543-2165-150-4-e81-b54","series-title":"JAMA Netw Open","first-page":"e2453588","article-title":"KRAS mutation status and treatment outcomes in patients with metastatic pancreatic adenocarcinoma","volume":"8","author":"Norton","year":"2025","unstructured":"Norton C,\nShaw MS,\nRubnitz Z, et al. KRAS mutation status and treatment outcomes in patients with metastatic pancreatic adenocarcinoma. JAMA Netw Open. 2025;8(1):e2453588. doi:10.1001\/jamanetworkopen.2024.53588"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/4\/article-pe81.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/doi\/10.5858\/arpa.2024-0502-RA\/3515020\/10.5858_arpa.2024-0502-ra.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/4\/article-pe81.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/4\/article-pe81.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:33:43Z","timestamp":1775003623000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/4\/article-pe81.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":108,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2024-0502-ra","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}